Affinor Growers Inc.
CNSX : AFI
FRANKFURT : 1AF
OTCQB : RSSFF

Affinor Growers Inc.

January 05, 2015 10:32 ET

Affinor Growers: Herbal Analytics Signs 2-Year Contract with Medical Producer as Cannabis Laboratory

MONTREAL, CANADA--(Marketwired - Jan. 5, 2015) - Affinor Growers (CSE:AFI)(FRANKFURT:1AF)(OTCQB:RSSFF) ("Affinor" or the "Corporation) announces that Herbal Analytics LLC has signed a 2 year contract to be the cannabis laboratory for Green Color and Arches (GC&A), a producer of medical products.

GC&A has agreed to engage Herbal Analytics to exclusively study their cannabis for compound research and drug discovery purposes. Within the terms of the Agreement, Herbal Analytics will also provide services such as:

  • Quality assurance testing

  • Bi-weekly condition testing of planted material;

  • As needed testing for future crop selection

  • As needed consulting services on data

  • As needed courier service.

After further classifications are received, additional fees not included in the Agreement, will come from Extraction testing.

About Affinor Growers Inc.

Affinor Growers is a diversified publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, strawberries and high quality medical Marijuana. Affinor is committed to becoming a pre-eminent grower, using exclusive vertical farming techniques.

On Behalf of the Board of Directors

AFFINOR GROWERS INC.

"Sebastien Plouffe", President & CEO

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Contact Information